Revance Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

SEC filing history

Showing 701-725 of 946 matching filings.

Per page
25
Current page
29
8-K File 001-36297

8-K

Filing date
05 Jan 2017
Reporting date
05 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jan 2017
Reporting date
30 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Dec 2016
Reporting date
28 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Dec 2016
Reporting date
14 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

FORM 8-K

Filing date
12 Dec 2016
Reporting date
12 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Nov 2016
Reporting date
25 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
03 Nov 2016
Reporting date
03 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
28 Oct 2016
Reporting date
26 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Aug 2016
Reporting date
12 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
04 Aug 2016
Reporting date
04 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 333-193154

CT ORDER filing

Filing date
22 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
06 Jul 2016
Reporting date
01 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
06 Jul 2016
Reporting date
01 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Jul 2016
Reporting date
30 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
05 Jul 2016
Reporting date
01 Jul 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2016
Reporting date
13 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 May 2016
Reporting date
19 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 May 2016
Reporting date
19 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
23 May 2016
Reporting date
19 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 May 2016
Reporting date
09 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .